Haley Payne

Haley Payne supports clients with evidence-based research and analysis that spans a variety of healthcare sectors and stakeholders.

She applies her background in vaccines, public health policy, and infectious diseases to a broad range of client needs.

Prior to joining Avalere, Haley was the public health policy manager at the Infectious Diseases Society of America, where she implemented the society’s policy activities around COVID-19, including vaccine authorization and distribution, and coordinated policy activities to combat antibiotic resistance and emerging infectious diseases. Previously, she served as a legislative associate at the Health and Medicine Counsel, where she represented a variety of patient and provider organizations on Capitol Hill.

Haley has an MPH from George Washington University and a BA in political science from Indiana University.

Authored Content

The COVID-19 pandemic has brought renewed attention and urgency to mitigating access barriers to recommended vaccines.

The COVID-19 pandemic response has increased investment in vaccine innovations, but also exposed gaps in US and global vaccine access and delivery.

As the COVID-19 pandemic draws to a close in the US, another public health concern is once again coming to the fore: antimicrobial resistance (AMR).